Source - SMW
Numis today reaffirms its add investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 2640p.



Broker Forecasts data provided by www.sharesmagazine.co.uk

Related Charts

Dechra Pharmaceuticals (DPH)

0.00 (0.00%)
delayed 17:30PM